| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |